These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38869921)

  • 1. COping with acute sickle cell hemolysis.
    Chonat S; Stowell SR
    Blood; 2024 Jun; 143(24):2452-2453. PubMed ID: 38869921
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!
    Gladwin MT; Kato GJ
    Haematologica; 2008 Jan; 93(1):1-3. PubMed ID: 18166776
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing delayed hemolytic transfusion reactions in sickle cell disease.
    Castro O; Oneal P; Medina A; Onojobi G; Gordeuk VR
    Transfusion; 2016 Nov; 56(11):2899-2900. PubMed ID: 28211954
    [No Abstract]   [Full Text] [Related]  

  • 4. Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.
    Guarda CCD; Santiago RP; Fiuza LM; Aleluia MM; Ferreira JRD; Figueiredo CVB; Yahouedehou SCMA; Oliveira RM; Lyra IM; Gonçalves MS
    Expert Rev Hematol; 2017 Jun; 10(6):533-541. PubMed ID: 28482712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease.
    Gbotosho OT; Kapetanaki MG; Kato GJ
    Front Immunol; 2020; 11():561917. PubMed ID: 33584641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain.
    Taylor JG; Nolan VG; Mendelsohn L; Kato GJ; Gladwin MT; Steinberg MH
    PLoS One; 2008 May; 3(5):e2095. PubMed ID: 18461136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priapism in patients with hemolytic disorders: a nationwide retrospective cohort study.
    Tranekær S; Hansen DL; Biemond BJ; Sørensen AL; Glenthøj A; Petersen J; Frederiksen H
    Ann Hematol; 2021 Aug; 100(8):1947-1951. PubMed ID: 34136949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.
    Kato GJ; Gladwin MT; Steinberg MH
    Blood Rev; 2007 Jan; 21(1):37-47. PubMed ID: 17084951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculature and kidney complications in sickle cell disease.
    Nath KA; Katusic ZS
    J Am Soc Nephrol; 2012 May; 23(5):781-4. PubMed ID: 22440903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous sickle cell disease with coexistent hereditary spherocytosis in three siblings.
    Maurer HS; Vida LN; Honig GR
    J Pediatr; 1972 Feb; 80(2):235-42. PubMed ID: 5008820
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolysis-associated priapism in sickle cell disease.
    Nolan VG; Wyszynski DF; Farrer LA; Steinberg MH
    Blood; 2005 Nov; 106(9):3264-7. PubMed ID: 15985542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysis and hemolysis-related complications in females vs. males with sickle cell disease.
    Raslan R; Shah BN; Zhang X; Kanias T; Han J; Machado RF; Gladwin MT; Gordeuk VR; Saraf SL
    Am J Hematol; 2018 Nov; 93(11):E376-E380. PubMed ID: 30117177
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperhemolysis syndrome in a patient with sickle cell disease with erythrophagocytosis in peripheral blood.
    Islam MS; Chia L
    Eur J Haematol; 2010 Feb; 84(2):188. PubMed ID: 19744126
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Bartolucci P
    Rev Med Interne; 2023 Nov; 44(4S1):4S7-4S11. PubMed ID: 38049244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhemolytic transfusion reaction in sickle cell disease.
    Win N; Doughty H; Telfer P; Wild BJ; Pearson TC
    Transfusion; 2001 Mar; 41(3):323-8. PubMed ID: 11274584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Long-term efficacy and safety of L-glutamine in preventing sickle cell disease-related acute complications and hemolysis in pediatric and adult patients-Real-world, observational study".
    Elenga N; Loko G; Etienne-Julan M; Al-Okka R; Adel AM; Yassin MA
    Eur J Haematol; 2023 Jun; 110(6):772-773. PubMed ID: 36732400
    [No Abstract]   [Full Text] [Related]  

  • 17. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
    Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
    Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Anaemic crisis in sickle-cell disease.
    Br Med J; 1975 Aug; 3(5982):502-3. PubMed ID: 1164603
    [No Abstract]   [Full Text] [Related]  

  • 19. Massive hemolysis during sickle cell crisis.
    Parker DL; Parker JM; Stoltzfus GB
    Ohio State Med J; 1969 May; 65(5):495-6. PubMed ID: 4891298
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.